SRSF3 and non-small cell lung carcinoma: To address this concern, we have designed a NSCLC-targeting LNP carrying the SRSF3 siRNA, which was shown to efficiently knock down SRSF3 and induce senescence in A549 cells (Figure 6) and will be an important material in further in vivo studies toward future therapeutic applications.